2025
SJR Q2
JCR Q3 · 1,2
40 matched articles
SCIE
Journal detail
Journal of Cutaneous Pathology
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0303698716000560
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,509
- Quartile Q2
- H-Index 94
- Cites/doc 1,29
- Docs (3y) 555
- Cites (3y) 719
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 1,2
- 5Y JIF 1,2
- JCI 0,47
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Dermatology Q2
- Histology Q3
- Pathology and Forensic Medicine Q2
Areas
- Medicine
WoS categories
- Dermatology | Pathology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,509 | 1,2 | 1,2 | 0,47 | Q3 | 94 |
| 2024 | Q2 | Q3 | 0,564 | 1,1 | 1,3 | 0,56 | Q3 | 89 |
| 2023 | Q2 | Q3 | 0,563 | 1,6 | 1,5 | 0,56 | Q3 | 89 |
| 2022 | Q2 | Q3 | 0,574 | 1,7 | 1,6 | 0,52 | Q3 | 89 |
| 2021 | Q3 | Q4 | 0,369 | 1,5 | 1,6 | 0,44 | Q3 | 89 |
| 2020 | Q2 | Q4 | 0,597 | 1,6 | 1,7 | 0,52 | Q3 | 89 |
| 2019 | Q2 | Q3 | 0,622 | 1,4 | 1,4 | 0,59 | Q3 | 89 |
| 2018 | — | Q3 | — | 1,5 | 1,4 | 0,59 | Q3 | — |
| 2017 | Q2 | Q3 | 0,66 | 1,5 | 1,4 | 0,61 | Q3 | 89 |
| 2016 | Q2 | Q3 | 0,581 | 1,3 | 1,4 | — | — | 89 |
| 2015 | Q2 | Q3 | 0,667 | 1,4 | 1,5 | — | — | 89 |
| 2014 | Q2 | Q2 | 0,747 | 1,6 | 1,5 | — | — | 89 |
| 2013 | Q1 | Q2 | 0,859 | 1,6 | 1,6 | — | — | 89 |
| 2012 | Q1 | Q2 | 0,911 | 1,8 | 1,5 | — | — | 89 |
| 2011 | Q1 | Q2 | 0,963 | 1,6 | 1,6 | — | — | 89 |
| 2010 | Q1 | Q2 | 0,805 | 1,7 | 1,8 | — | — | 89 |
| 2009 | — | Q3 | — | 1,5 | 1,7 | — | — | — |
| 2008 | — | Q3 | — | 1,6 | 1,8 | — | — | — |
| 2007 | — | Q3 | — | 1,4 | 1,6 | — | — | — |
| 2006 | — | Q2 | — | 1,6 | — | — | — | — |
| 2005 | — | Q2 | — | 1,3 | — | — | — | — |
| 2004 | — | Q2 | — | 1,2 | — | — | — | — |
| 2003 | — | Q2 | — | 1,6 | — | — | — | — |
| 2002 | — | Q2 | — | 1,3 | — | — | — | — |
| 2001 | — | Q2 | — | 1,1 | — | — | — | — |
| 2000 | — | Q2 | — | 1,2 | — | — | — | — |
| 1999 | — | Q1 | — | 1,7 | — | — | — | — |
| 1998 | — | Q2 | — | 1,4 | — | — | — | — |
| 1997 | — | Q2 | — | 1,2 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | DERMATOLOGY | SCIE | Q3 | Q3 | 73/99 |
| 2025 | PATHOLOGY | SCIE | Q4 | Q4 | 68/89 |
| 2024 | DERMATOLOGY | SCIE | Q4 | Q3 | 74/96 |
| 2024 | PATHOLOGY | SCIE | Q3 | Q3 | 66/90 |
| 2023 | DERMATOLOGY | SCIE | Q3 | Q3 | 57/94 |
| 2023 | PATHOLOGY | SCIE | Q3 | Q3 | 53/88 |
| 2022 | DERMATOLOGY | SCIE | Q3 | Q3 | 50/70 |
| 2022 | PATHOLOGY | SCIE | Q3 | Q3 | 57/76 |
| 2021 | DERMATOLOGY | SCIE | Q4 | Q3 | 58/69 |
| 2021 | PATHOLOGY | SCIE | Q4 | Q3 | 60/77 |
| 2020 | DERMATOLOGY | SCIE | Q4 | Q3 | 56/69 |
| 2020 | PATHOLOGY | SCIE | Q4 | Q3 | 60/77 |
| 2019 | DERMATOLOGY | SCIE | Q4 | Q3 | 52/68 |
| 2019 | PATHOLOGY | SCIE | Q3 | Q3 | 58/78 |
| 2018 | DERMATOLOGY | SCIE | Q3 | Q3 | 45/66 |
| 2018 | PATHOLOGY | SCIE | Q3 | Q3 | 51/76 |
| 2017 | DERMATOLOGY | SCIE | Q3 | Q3 | 40/64 |
| 2017 | PATHOLOGY | SCIE | Q3 | Q3 | 54/79 |
| 2016 | DERMATOLOGY | SCIE | Q3 | — | 42/63 |
| 2016 | PATHOLOGY | SCIE | Q3 | — | 58/79 |
| 2015 | DERMATOLOGY | SCIE | Q3 | — | 37/61 |
| 2015 | PATHOLOGY | SCIE | Q3 | — | 54/79 |
| 2014 | DERMATOLOGY | SCIE | Q2 | — | 30/63 |
| 2014 | PATHOLOGY | SCIE | Q3 | — | 50/76 |
| 2013 | DERMATOLOGY | SCIE | Q2 | — | 30/61 |
| 2013 | PATHOLOGY | SCIE | Q3 | — | 56/76 |
| 2012 | DERMATOLOGY | SCIE | Q2 | — | 23/59 |
| 2012 | PATHOLOGY | SCIE | Q3 | — | 46/77 |
| 2011 | DERMATOLOGY | SCIE | Q2 | — | 28/58 |
| 2011 | PATHOLOGY | SCIE | Q3 | — | 48/79 |
| 2010 | DERMATOLOGY | SCIE | Q2 | — | 26/55 |
| 2010 | PATHOLOGY | SCIE | Q3 | — | 40/76 |
| 2009 | DERMATOLOGY | SCIE | Q3 | — | 27/48 |
| 2009 | PATHOLOGY | SCIE | Q3 | — | 44/71 |
| 2008 | DERMATOLOGY | SCIE | Q3 | — | 24/43 |
| 2008 | PATHOLOGY | SCIE | Q3 | — | 41/69 |
| 2007 | DERMATOLOGY | SCIE | Q3 | — | 22/41 |
| 2007 | PATHOLOGY | SCIE | Q3 | — | 42/66 |
| 2006 | DERMATOLOGY | SCIE | Q2 | — | 17/39 |
| 2006 | PATHOLOGY | SCIE | Q3 | — | 35/64 |
| 2005 | DERMATOLOGY | SCIE | Q2 | — | 19/39 |
| 2005 | PATHOLOGY | SCIE | Q3 | — | 38/66 |
| 2004 | DERMATOLOGY | SCIE | Q2 | — | 18/38 |
| 2004 | PATHOLOGY | SCIE | Q3 | — | 43/65 |
| 2003 | DERMATOLOGY | SCIE | Q2 | — | 12/38 |
| 2003 | PATHOLOGY | SCIE | Q2 | — | 29/64 |
| 2002 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q2 | — | 15/40 |
| 2002 | PATHOLOGY | SCIE | Q3 | — | 33/64 |
| 2001 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q2 | — | 15/38 |
| 2001 | PATHOLOGY | SCIE | Q3 | — | 36/66 |
| 2000 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q2 | — | 15/36 |
| 2000 | PATHOLOGY | SCIE | Q3 | — | 35/67 |
| 1999 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q1 | — | 8/36 |
| 1999 | PATHOLOGY | SCIE | Q2 | — | 18/66 |
| 1998 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q2 | — | 9/35 |
| 1998 | PATHOLOGY | SCIE | Q2 | — | 22/68 |
| 1997 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q2 | — | 9/32 |
| 1997 | PATHOLOGY | SCIE | Q2 | — | 26/66 |